Not checkedNot checked for notices yet.

Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma

Santiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Vanesa García-Barberán and 8 more

Therapeutic Advances in Medical Oncology · 2022

doi:10.1177/17588359221100863 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References49

30.
Re-epithelialization and immune cell behaviour in an ex vivo human skin model · 2020
31.
Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis · 2020
36.
A decade of immune-checkpoint inhibitors in cancer therapy · 2020

37 more references, whose wording the paper’s licence keeps private.

All 49 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.